Author:
Zhou Lin,Ao Luyao,Yan Yunyi,Li Chengyuan,Li Wanting,Ye Anqi,Liu Jihua,Hu Yahui,Fang Weirong,Li Yunman
Funder
National Major Scientific and Technological Special Project for “Significant New Drugs Development” during the Thirteenth Five-year Plan Period
National Natural Science Foundation of China
the “Double First-Class” Construction Technology Innovation Team Project of China Pharmaceutical University
Postgraduate Research & Practice Innovation Program of Jiangsu Province
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Neurology (clinical),Pharmacology
Reference59 articles.
1. Bessaguet F, Danigo A, Bouchenaki H et al. Neuroprotective effect of angiotensin II type 2 receptor stimulation in vincristine-induced mechanical allodynia. Pain 2018;159(12):2538–46.
2. Wang Y, Cao SE, Tian J et al. Auraptenol attenuates vincristine-induced mechanical hyperalgesia through serotonin 5-HT1A receptors. Sci Rep 2013;3:3377.
3. Mora E, Smith EM, Donohoe C, Hertz DL. Vincristine-induced peripheral neuropathy in pediatric cancer patients. Am J Cancer Res 2016;6(11):2416–30.
4. Jackson DV, Jr., Castle MC, Poplack DG, Bender RA. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates. Cancer Res 1980;40(3):722–4.
5. Geisler S, Doan RA, Strickland A et al. Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice. Brain 2016;139(Pt 12):3092–108.
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献